IRIS
ALGERI, MATTIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 320
NA - Nord America 201
EU - Europa 188
AF - Africa 1
SA - Sud America 1
Totale 711
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 281
US - Stati Uniti d'America 201
IT - Italia 84
CN - Cina 24
DE - Germania 23
NL - Olanda 20
AT - Austria 18
GB - Regno Unito 17
FI - Finlandia 13
IN - India 5
FR - Francia 4
UA - Ucraina 4
HK - Hong Kong 3
SA - Arabia Saudita 3
IE - Irlanda 2
IR - Iran 2
PL - Polonia 2
TW - Taiwan 2
AR - Argentina 1
RU - Federazione Russa 1
TN - Tunisia 1
Totale 711
Salva come PNG Salva come JPEG
Città #
Santa Clara 150
Singapore 96
Beijing 21
Rome 18
Helsinki 12
Nuremberg 12
Milan 11
London 9
Palermo 8
Amsterdam 7
Vallefiorita 6
Ashburn 4
Boardman 4
Islington 4
San Nicola Manfredi 4
Allen 3
Gavoi 3
Hong Kong 3
Munich 3
Pontirolo Nuovo 3
Pune 3
Teverola 3
Vienna 3
Buffalo 2
Detroit 2
Landshut 2
Miami 2
Naples 2
New Delhi 2
New York 2
Pittsburgh 2
Riyadh 2
Sassari 2
Tehran 2
Xi'an 2
Arezzo 1
Buenos Aires 1
Cheyenne 1
Espoo 1
Frankfurt am Main 1
Gdansk 1
Honolulu 1
Khobar 1
Manassas 1
Philadelphia 1
Rockville 1
San Jose 1
Secaucus 1
Washington 1
Totale 428
Salva come PNG Salva come JPEG
Nome #
GD2-CART01 for Relapsed or Refractory High-Risk Neuroblastoma 30
In vitro Cytotoxic Effect of Trabectedin on JMML AND CMML Cell Populations 26
Allogeneic, donor-derived, second-generation, CD19-directed CAR-T cells for the treatment of pediatric relapsed/refractory BCP-ALL 25
Outcomes of children and young adults with B-cell acute lymphoblastic leukemia given blinatumomab as last consolidation treatment before allogeneic hematopoietic stem cell transplantation 17
Betibeglogene autotemcel gene therapy for non–β0/β0 genotype β-thalassemia 17
Remestemcel-L for the treatment of graft versus host disease 16
Ruxolitinib as the first post-steroid treatment for acute and chronic graft-versus-host disease 14
Exagamglogene Autotemcel for Transfusion-Dependent β-Thalassemia 14
Novel approaches to diagnosis and treatment of Juvenile Myelomonocytic Leukemia 13
FINAL RESULTS OF THE PHASE 3 STUDIES NORTHSTAR-2 AND NORTHSTAR-3 IN PATIENTS WITH TRANSFUSION-DEPENDENT β-THALASSEMIA (TDT): SUBGROUP ANALYSIS OF ITALIAN PATIENTS TREATED WITH BETIBEGLOGENE AUTOTEMCEL (BETI-CEL), LENTIGLOBIN FOR THALASSEMIA 12
IMPACT OF POST-TRANSPLANT INFUSION OF DONOR T CELLS GENETICALLY MODIFIED WITH INDUCIBLE CASPASE 9 SUICIDE GENE (BPX-501 CELLS) ON CHILDREN WITH LEUKEMIA GIVEN ALPHA-BETA T-CELL DEPLETED HAPLO-HSCT 12
Alpha/beta T-cell depleted Haploidentical HSCT followed by infusion of donor lymphocytes transduced with inducible caspase9 gene is safe and effective for patients with erythroid disorders 11
CAR.CD123-NK Cells Have an Equally Effective but Safer Off-Tumor/on-Target Profile As Compared to CARCD123-T Cells for the Treatment of Acute Myeloid Leukaemia 10
Availability of HLA-allele-matched unrelated donors and registry size: Estimation from haplotype frequency in the Italian population 10
GENERATION OF CYTOTOXIC T LYMPHOCYTES BY DONOR-SPECIFIC CSE PEPTO WT1 AND WITH CYTOTOXIC ACTIVITY TOWARDS LEUKEMIC BLASTS OF THE PATIENT FOR ADOPTIVE IMMUNOTHERAPY AFTER ALLOGENEIC HEMATOPOIETIC STEM CELLS. 9
Outcome of children with acute leukemia given allogeneic HSCT either from an unrelated donor (UD-HSCT) or from an HLA-partially matched relative after αß-T cell/B-cell depletion (αßhaplo-HSCT) 9
Clinical Outcomes after Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Transfusion-Dependent β-Thalassemia Treated at the Bambino Gesù Children's Hospital, Rome, Italy 9
Comprehensive characterization of bone-marrow mesenchymal stromal cells isolated from patients affected by primary immunodeficiency 9
Engineered mucoperiosteal scaffold for cleft palate regeneration towards the non-immunogenic transplantation 9
Biological and functional characterization of bone marrow-derived mesenchymal stromal cells isolated from pediatric patients affected by acute myeloid leukemia 9
T-cell depleted HLA-haploidentical HSCT in a child with neuromyelitis optica 8
The role of allogeneic hematopoietic stem cell transplantation in pediatric leukemia 8
Improved T- and B-Cell Neogenesis in Children with Acute Leukemia Given an Alpha-Beta T-Cell Depleted Haplo-HSCT Combined with the Infusion of Donor T-Cells Genetically Modified with Inducible Caspase 9 Suicide Gene (Rivo-cel) 8
Natural history of Ras‐associated autoimmune leukoproliferative disorder: A 20-year follow-up of a NRAS-mutated patient excluding a malignant progression 8
Impact of Treosulfan Exposure on Early and Long-Term Clinical Outcomes in Pediatric Allogeneic Hematopoietic Stem Cell Transplantation Recipients: A Prospective Multicenter Study 8
TCRab/CD19 depleted HSCT from an HLA-haploidentical relative to treat children with different nonmalignant disorders 8
Characterization of Bone Marrow Infiltrate of Immune-mediated Graft Failure after Allogeneic Hematopoietic Stem Cell Transplantation 8
Resistance to neoplastic transformation of ex-vivo expanded human mesenchymal stromal cells after exposure to supramaximal physical and chemical stress 8
Identification of New Soluble Factors Correlated With the Development of Graft Failure After Haploidentical Hematopoietic Stem Cell Transplantation 8
Donor T Cells Genetically Modified with a Novel Suicide Gene (inducible Caspase 9, iC9) Expand and Persist over Time after Post-Allograft Infusion in Patients Given αβ T-Cell and B-Cell Depleted HLA-Haploidentical Allogeneic Stem Cell Transplantation (αβ haplo-HSCT) Contributing to Accelerate Immune Recovery 8
THE USE OF BPX-501 DONOR T CELL INFUSION (WITH INDUCIBLE CASPASE 9 SUICIDE GENE) TOGETHER WITH HLA-HAPLOIDENTICAL STEM CELL TRANSPLANT TO TREAT CHILDREN WITH HEMOGLOBINOPATHIES AND ERYTHROID DISORDERS 8
Decellularized esophageal tubular scaffold microperforated by quantum molecular resonance technology and seeded with mesenchymal stromal cells for tissue engineering esophageal regeneration 8
Clinical, Immunological, and Molecular Variability of RAG Deficiency: A Retrospective Analysis of 22 RAG Patients 8
Autologous CD19‐Targeting CAR T Cells in a Patient With Refractory Juvenile Dermatomyositis 7
Treosulfan Exposure in Pediatric Hematopoietic Stem Cell Transplantation is Associated with Early Toxicity but not with event-free Survival 7
Allogeneic CD19-CAR T cells: a promising treatment for pediatric patients with highly refractory BCP-ALL relapsing after allogeneic hematopoietic stem cells transplant (allo-HSCT) 7
A new BSA-based Threshold Predicts Optimal PBSC Collection in T-cell Depleted HLA-haploidentical Stem Cell Transplantation 7
NIRMATRELVIR/RITONAVIR AND TIXAGEVIMAB/CILGAVIMAB AS SARS-COV-2 TREATMENT IN PEDIATRIC AND YOUNG ADULT PATIENTS AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT) OR CD19-DIRECTED CAR T-CELL TREATMENT 7
Efficacy of third-party chimeric antigen receptor modified peripheral blood natural killer cells for adoptive cell therapy of B-cell precursor acute lymphoblastic leukemia 7
HLA-haploidentical TCRab1/CD191-depleted stem cell transplantation in children and young adults with Fanconi anemia 7
ABATACEPT REDUCES ACUTE GVHD INCIDENCE IN PEDIATRIC PATIENTS TRANSPLANTED FROM HLA-MISMATCHED UNRELATED DONORS 7
Outcome of Children with Acute Leukemia Given Allogeneic HSCT Either from an Unrelated Donor or from an HLA-Partially Matched Relative after αβ-T Cell/B-Cell Depletion: A Multicenter, Retrospective, Comparative Analysis of the AIEOP Network 7
T-Cell Depleted HLA-Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation (haplo-HSCT) Followed By Donor Lymphocyte Infusion with T Cells Transduced with the Inducible Caspase 9 (iC9) Suicide Gene in Children with Hematological Malignancies 7
Human leukocyte antigen evolutionary divergence influences outcomes of paediatric patients and young adults affected by malignant disorders given allogeneic haematopoietic stem cell transplantation from unrelated donors 7
TCRαβ +/CD19 + - Depleted HLA-Haploidentical Hematopoietic Stem Cell Traansplantation in Pediatric Patient with Fanconi Anemia 7
Decolonization of multi-drug resistant bacteria by fecal microbiota transplantation in five pediatric patients before allogeneic hematopoietic stem cell transplantation: Gut microbiota profiling, infectious and clinical outcomes 7
BPX-501 DONOR T CELL INFUSION (WITH INDUCIBLE CASPASE 9 SUICIDE GENE) FACILITATES HLA-HAPLOIDENTICAL STEM CELL TRANSPLANT IN CHILDREN WITH BOTH HEMATOLOGICAL MALIGNANCIES AND NON-MALIGNANT CONDITIONS 7
Biological and functional characterization of bone marrow-derived mesenchymal stromal cells from patients affected by primary immunodeficiency 6
Autologous gene therapy for hemoglobinopathies: From bench to patient's bedside 6
Outcomes of children with primary immunodeficiencies receiving alpha/beta T-cell depleted HLA-haplo-HSCT followed by infusion of lymphocytes transduced with the inducible caspase 9 (iC9) suicide gene 6
Outcome of children with ALL in second complete remission transplanted from an unrelated donor: a retrospective analysis 6
Clinical Outcome and Immune Recovery after Adoptive Infusion of BPX-501 Cells (donor T cells transduced with iC9 suicide gene) in Children with Hemoglobinopathies and Diamond-Blackfan Anemia Given α/β T-Cell Depleted HLA-Haploidentical Stem Cell Transplantation (HSCT) 6
Strategies To Increase CAR T-Cell Safety and to Prevent Epitope Masking In CAR plus B-Cell Leukemia Blasts 6
T- and B-Cell Neogenesis Recovers Efficiently in Children with Acute Leukemia Given an Alpha-Beta T-Cell Depleted Haplo-HSCT Followed By Infusion of Donor T-Cells Genetically Modified with Inducible Caspase 9 Suicide Gene (BPX-501 cells) 6
Bispecific Antibodies and Other Non-CAR Targeted Therapies and HSCT: Decreased Toxicity for Better Transplant Outcome in Paediatric ALL? 6
Updated Analysis on the Outcomes of Children with Acute Leukemia (AL) Receiving an Alpha/Beta T and B-Cell Depleted HLA-Haploidentical Hematopoietic Stem Cell Transplantation (TBdepl-haploHSCT) 6
Management of pediatric patients with anti-HLA antibodies undergoing T-cell depleted haploidentical hematopoietic stem cell transplantation 6
Mesenchymal stromal cells and chronic inflammatory bowel disease 6
Unmanipulated donor lymphocyte infusion (dli) after ab-t and b-cell depleted haploidentical stem cell transplantation 6
Results of a Multicentre, Randomized, Controlled Open-Label Study on the Use of Anti-T-Lymphocyte Globulin (ATLG) and Rituximab for Immunomodulation of Graft-Versus-Host Disease (GvHD) and Graft Failure (GF) in Patients with Non-Malignant Disorders 6
Gata2 related conditions and predisposition to pediatric myelodysplastic syndromes 6
Phenotypic and functional characterization of nk cells in αβt-cell and b-cell depleted haplo-hsct to cure pediatric patients with acute leukemia 6
P1361: TREATMENT OF SEVERE STEROID-REFRACTORY ACUTE GVHD WITH MESENCHYMAL STROMAL CELLS: RESULTS OF THE PHASE III RANDOMIZED DOUBLE-BLIND MULTI-CENTER HOVON-113 TRIAL 6
Alphabeta T and B-Cell Depleted HLA-Haploidentical Hematopoietic Stem Cell Transplantation (Tbdepl-Haplohsct) in Children with Non-Malignant Disorders 6
SUCCESS OF PERSONALIZED RUXOLITINIB TREATMENT BASED ON THERAPEUTIC DRUG MONITORING IN PEDIATRIC PATIENTS WITH PRIMARY AND SECONDARY HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS ALLOWING BRIDGING TO HSCT 5
Administration of BPX-501 Cells Following Αβ T and B-Cell-Depleted HLA-Haploidentical HSCT (haplo-HSCT) in Children with Malignant or Non-Malignant Disorders 5
Academic, Phase I/II Trial on T Cells Expressing a Second Generation, CD19-Specific Chimeric Antigen Receptor (CAR) and Inducible Caspase 9 Safety Switch for the Treatment of B-Cell Precursor Acute Lymphoblastic Leukemia (BCP-ALL) and B-Cell Non-Hodgkin Lymphoma (B-NHL) in Children 5
Alpha/Beta T-Cell and B-Cell Depletion HLA-Haploidentical Hematopoietic Stem Cell Transplantation Is an Effective Treatment for Children/Young Adults with Acute Leukemia 5
Novel compound heterozygous mutations in il-7 receptor α gene in a 15-month-old girl presenting with thrombocytopenia, normal t cell count and maternal engraftment 5
Fecal Microbiota Transplantation in Children to Treat Acute GVHD or multi-drug Resistant Bacteria Colonization 5
Busulfan, Cyclophosphamide and Melphalan As Conditioning Regimen for Pediatric Patients with AML in 1st or 2nd CR: A Retrospective Analysis from the AIEOP HSCT Registry 5
Patient-Derived Chimeric Antigen Receptor T-Cell Production Based on a Gammaretroviral Vector Platform Is Not Associated with Generation of CAR+ Leukemia Blasts 5
HLA EVOLUTIONARY DIVERGENCE INFLUENCES OUTCOMES OF ALLOGENEIC SCT FROM UNRELATED DONOR IN PEDIATRIC PATIENTS AND YOUNG ADULTS AFFECTED BY MALIGNANT DISORDERS 5
αβT- and B-cell-depleted HLA-haploidentical hematopoietic stem cell transplantation in children with myelodysplastic syndromes 5
OUTCOMES OF HLA-MISMATCHED HSCT WITH TCRAB/CD19 DEPLETION OR POST-TRANSPLANT CYCLOPHOSPHAMIDE FOR INBORN ERRORS OF IMMUNITY: ANALYSIS BY EBMT IEWP HAPLOHSCT IN IEI STUDY GROUP 5
Reconstitution Dynamics and Impact on Clinical Outcomes of Mucosal-Associated Invariant T-Cells in Pediatric Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation 5
Anti-T-Lymphocyte Globulin (ATLG) and Rituximab for Immunomodulation of Graft-Versus-Host Disease and Graft Failure in Patients with Non-Malignant Disorders: Results of a Multicentre, Randomized, Open-Label Study 5
Outcome of Children with Wiskott-Aldrich Syndrome (WAS) Given TCR Alpha-Beta/CD19 Depleted Hematopoietic Stem Cell Transplantation (HSCT) from an HLA-Haploidentical Relative 5
Mucosal-Associated Invariant T (MAIT) Cells Are Functionally Impaired in Pediatric Patients Following HCT and Their Recovery Is Associated with the Onset of GvHD 5
Effective rapid diagnosis of bacterial bloodstream infections by t2 magnetic resonance technology in pediatric hematopoietic stem cell transplantation 5
Implementation of a quality system for running a cell and gene therapy clinical trial within a JACIE-accredited transplant program 5
CD19 REDIRECTED CAR NK CELLS ARE EQUALLY EFFECTIVE BUT LESS TOXIC THAN CAR T CELLS IN ACUTE LYMPHOBLASTIC LEUKEMIA 5
Role of interferon-γ in immune-mediated graft failure after allogeneic hematopoietic stem cell transplantation 5
Use of ruxolitinib to control graft-versus-host–like disease in Omenn syndrome and successfully bridging to HSCT 5
Use of emapalumab in the peri-transplant period to prevent graft failure in patients at risk 5
T Cell-Depleted and T Cell-Replete HLA-Haploidentical Stem Cell Transplantation for Non-malignant Disorders 5
Tisagenlecleucel therapy for relapsed or refractory B-cell acute lymphoblastic leukaemia in infants and children younger than 3 years of age at screening: an international, multicentre, retrospective cohort study 5
Pembrolizumab (and friends) in pediatric malignancies: should we consider Hodgkin lymphoma a world of its own? 5
HLA-haploidentical stem cell transplantation in children with inherited bone marrow failure syndromes: A retrospective analysis on behalf of EBMT severe aplastic Anemia and pediatric diseases working parties 4
Comprehensive characterization of mesenchymal stromal cells from patients with Fanconi anaemia 4
Alphabeta T and B-Cell Depleted HLA-Haploidentical Hematopoietic Stem Cell Transplantation (TBdepl-haploHSCT) in Children with Myelodysplastic Syndromes 4
Successful T-cell-depleted Haploidentical Hematopoietic Stem Cell Transplantation in a Child with Dyskeratosis Congenita after a Fludarabine-based Conditioning Regimen 4
Outcome of Children with Different Non-Malignant Disorders Given Alphabeta T and B-Cell Depleted HLA-Haploidentical Hematopoietic Stem Cell Transplantation (TBdepl-haploHSCT) 4
Matched unrelated donor transplantation versus haploidentical transplantation with post-transplant cyclophosphamide in children with acute myeloid leukemia: a PDWP-EBMT study 4
Health-related quality of life in patients with steroid-refractory acute graft-versus-host disease 4
Safe and effective off-the-shelf immunotherapy based on CAR.CD123-NK cells for the treatment of acute myeloid leukaemia 4
Hematopoietic Stem Cell Transplantation in Thalassemia 4
Use of abatacept as GVHD prophylaxis in pediatric patients undergoing HSCT from matched or mismatched unrelated donor 4
TCRαβ/CD19 cell–depleted HLA-haploidentical transplantation to treat pediatric acute leukemia: updated final analysis 4
LONG-TERM DATA ON IMMUNE MONITORING OF CHILDREN GIVEN TCRαβ/CD19 CELL DEPLETED HLA-HAPLOIDENTICAL STEM TRANSPLANTATION (HAPLO-HSCT) 4
Totale 753
Salva come PNG Salva come JPEG
Categoria #
all - tutte 9.399
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.399
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202412 0 0 0 0 0 0 0 0 0 0 12 0
2024/2025898 4 0 3 402 66 165 60 29 95 70 4 0
Totale 910